PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis

Publisher： Karger

E-ISSN： 1662-6575|10|2|473-478

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.10, Iss.2, 2017-05, pp. : 473-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis

By  

ANNALS OF NEUROLOGY, Vol. 83, Iss. 1, 2018-01 ,pp. : 166-177

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical, Immunological and Therapeutic Aspects of Autoimmune Encephalitis

By  

Recent Patents on CNS Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 16-22

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia

By  

ANNALS OF NEUROLOGY, Vol. 83, Iss. 1, 2018-01 ,pp. : 40-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low programmed cell death‐1 (PD‐1) expression in peripheral CD4+ T cells in Japanese patients with autoimmune type 1 diabetes

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 180, Iss. 3, 2015-06 ,pp. : 452-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preclinical assessments of the MEK inhibitor PD‐0325901 in a mouse model of Neurofibromatosis type 1

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 10, 2015-10 ,pp. : 1709-1716

John Wiley & Sons Inc

Access to resources Recommend Favorite